483
Khaled Tawansy, MDKhaled Tawansy, MD – FDA 483, Aug 24, 2022
Record Details
An FDA inspection of Khaled Tawansy, MD, a clinical investigator in Los Angeles, CA, revealed a significant issue regarding the conduct of an investigation. The Principal Investigator failed to provide adequate oversight of study site personnel. This led to uncertified Clinical Research Coordinators performing protocol-specific assessments, which was not in accordance with the investigational plan.
View Company Profile
ID · b1f65825-1381-4f9e-891c-3b84af3f4ebd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.